Business Insider North Carolina
SEE OTHER BRANDS

Your business and economy news from North Carolina

Business Insider North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Insider North Carolina.

Press releases published on April 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Pony AI Inc. (“Pony” or the “Company”) (NASDAQ: PONY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

HPQ Silicium : Correction de communiqués antérieurs

HPQ Silicium : Correction de communiqués antérieurs

En réponse à une demande formulée par l’Autorité des marchés financiers, HPQ Silicium procède à la publication d’un communiqué rectificatif visant à corriger certaines informations à caractère prospectif diffusées dans des communiqués antérieurs. MONTRÉAL, …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Vita Coco Company, Inc. (“Vita Coco” or the “Company”) (NASDAQ: COCO). Such investors are advised to contact Danielle Peyton at newaction@ …

Willms and Associates Named Rockford Mutual 2024 Agency of the Year

Willms and Associates Named Rockford Mutual 2024 Agency of the Year

Rockford, Illinois, April 25, 2025 (GLOBE NEWSWIRE) -- ROCKFORD, Illinois – The Willms …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM).  Such investors are advised to contact Danielle Peyton at newaction@ …

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025

PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Northrop Grumman Corporation (“Northrop Grumman” or the “Company”) (NYSE: NOC). Such investors are advised to contact Danielle Peyton at newaction@ …

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …

DTE Completes Construction on Pine River Solar Park

DTE Completes Construction on Pine River Solar Park

Detroit, April 25, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE:DTE), Michigan’s largest producer of and investor in renewable energy, announced that construction has been completed at Pine River Solar Park during a ribbon-cutting ceremony at the site today. …

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings …

Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit

Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit

Hong Kong, April 25, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, the "Towards the Light: Co-creating a New Global Journey in the AI Field — 2025 AI Intelligent Development Summit" grandly opened at the Hop Hing Hotel in Hong Kong, China. This forum focused …

SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED

SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED

Corporate Rebranding Marks New Era of Engineering Excellence and Sustainable Solutions SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- SAG Holdings Limited today announced that it has changed its name to INNEOVA Holdings Limited (“INNEOVA Holdings” or the “ …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Open Lending Corp. - LPRO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Open Lending Corp. - LPRO

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Open Lending Corp. (“Open Lending” or the “Company”) (NASDAQ: LPRO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service